Pharma
AMD is making a $20 million equity investment to bolster Absci's drug discovery efforts and expand AMDs accelerators and ROCm software.
The partnership highlights the broader trend of AI-driven innovation in drug discovery and precision medicine.
The editors of Healthcare IT News, Healthcare Finance News and MobiHealthNews discuss the telehealth bill that was scuttled in 2024, as well as what's ahead in 2025 regarding the RPM market, physicians' pay schedule and cybersecurity policy.
Some leaders say AI will improve a massively inefficient, overpriced and difficult-to-access healthcare system, while others anticipate AI’s potential for earlier, more accurate diagnosis.
QuantHealth cofounder and CEO Orr Inbar discusses how using artificial intelligence for clinical trial simulations can help solve challenges often seen by patients, researchers and the pharmaceutical industry when studying a new drug.
HIMSS24
Emmanuel Bilbault, cofounder and CEO of POSOS, says the company's AI-driven international drug database's use of medication codes enables it to cross-reference EHR data and tailor prescriptions to meet a patient's specific needs.
Continuous Precision Medicine can help confirm a patient's pain medication intake so providers can better manage preventable issues, says the company's CEO and cofounder Steven Walther. However, accurate data is vital to ensuring validity.
HIMSS24
Dr. Colin Banas, CMO at DrFirst, discusses the company's medication adherence product. It uses AI to send texts that educate patients about medications and provides coupons and co-pay-assistance program information, if cost is an issue.
HIMSS24
The founder and president of Medonations, a Lebanese medication company, talks about the aftermath of the 2020 Beirut explosion and her medication-access relief efforts following the disaster.
European pharmacy experts, including leaders from Cleveland Clinic London and other organizations discuss Project Asclepius, a collaborative effort for digitizing pharmacy operations.